Beyond barrier protection, probiotics exert immunomodulatory effects by downregulating pro-inflammatory cytokines (tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1β, IL-6) and promoting anti-inflammatory responses, thereby attenuating the uncontrolled inflammation central to NEC pathogenesis [10]. This evidence concerns the gene TNF and necrotizing enterocolitis.